Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Revenue

In the year 2023, Teva Pharmaceutical had annual revenue of $15.85B with 6.17% growth. Revenue in the quarter ending December 31, 2023 was $4.46B with 14.75% year-over-year growth.

• Revenue (ttm): $15.85B
• Revenue Growth: +6.17%
• P/S Ratio: 1.00
• Revenue / Employee: $418,642
• Employees: 37,851
• Market Cap: 15.78B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	15.85B	921.00M	6.17%
Dec 31, 2022	14.93B	-953.00M	-6.00%
Dec 31, 2021	15.88B	-781.00M	-4.69%
Dec 31, 2020	16.66B	-228.00M	-1.35%
Dec 31, 2019	16.89B	-1.38B	-7.57%
Dec 31, 2018	18.27B	-3.58B	-16.39%
Dec 31, 2017	21.85B	-50.00M	-0.23%
Dec 31, 2016	21.90B	2.25B	11.45%
Dec 31, 2015	19.65B	-620.00M	-3.06%
Dec 31, 2014	20.27B	-42.00M	-0.21%
Dec 31, 2013	20.31B	-3.00M	-0.01%
Dec 31, 2012	20.32B	2.01B	10.95%
Dec 31, 2011	18.31B	2.19B	13.59%
Dec 31, 2010	16.12B	2.22B	15.99%
Dec 31, 2009	13.90B	2.81B	25.39%
Dec 31, 2008	11.09B	1.68B	17.83%
Dec 31, 2007	9.41B	1.00B	11.89%
Dec 31, 2006	8.41B	3.16B	60.15%
Dec 31, 2005	5.25B	451.00M	9.40%
Dec 31, 2004	4.80B	1.52B	46.47%
Dec 31, 2003	3.28B	757.80M	30.09%
Dec 31, 2002	2.52B	441.20M	21.24%
Dec 31, 2001	2.08B	327.50M	18.72%
Dec 31, 2000	1.75B	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.